Table 1. In vitro properties of DHFR mutant proteins a.
| Wild type | D27F | D27N | D27G | D27C | |
|---|---|---|---|---|---|
| kcat (s−1) | 13 ± 2 | (5 ± 1)×10−4 | (2.6 ± 0.9) × 10−2 | (1.8 ± 0.4)×10−2 | 3 ± 0.8 |
| KM (μM) | 0.8 ± 0.2 | (1.2 ± 0.6)×102 | (4 ± 1)×101 | 23 ± 7 | (7 ± 2)×101 |
| kcat/KM (s−1 μM−1) | 16 ± 1 | (4 ± 1)×10−6 | (7 ± 0.8)×10−4 | (8 ± 2)×10−4 | (4.2 ± 0.8)×10−2 |
| kcat/KM relative to wild type | - | 2 × 10−7 | 4 × 10−5 | 3 × 10−5 | 2 × 10−3 |
| Ki (nM) | 1.0 ± 0.3 | ND | ND | ND | (1.7 ± 0.7)×104 |
| ΔTm (0C) | - | +7.6 ± 0.1 b | +1.1 ± 0.3 | +1.2 ± 0.2 | +0.6 ± 0.6 |
| bis-ANS | 1 | 1.1 ± 0.1 | 2.9 ± 0.3 | 1.7 ± 0.3 | 2.2 ± 0.5 |
a Kinetic properties for dihydrofolate reductase catalytic activity (kcat = enzymatic turnover number, KM = Michaelis Menten constant, kcat/KM = catalytic efficiency, Ki = inhibition constant for trimethoprim) and protein stability properties (ΔTm = difference in melting temperature of folding with respect to wild type, bis-ANS = relative fluorescence from binding of bis-ANS to molten-globule intermediates with respect to wild type protein).